Melanoma
Results
Phase 3
This trial looked at pegylated interferon (also called peginterferon) to treat melanoma.
The trial was for people with an ulcerated melanoma that had grown into the skin (). There were no signs that their melanoma had spread to nearby or elsewhere in the body.
This trial was open for people to join between 2013 and 2017. The team published the results in 2020.
Recruitment start: 14 November 2013
Recruitment end: 25 January 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Poulam Patel
Doctor Alessandro Testori
Experimental Cancer Medicine Centre (ECMC)
European Organisation for Research and Treatment of Cancer (EORTC)
NIHR Clinical Research Network: Cancer
Last reviewed: 26 Jul 2021
CRUK internal database number: 11197
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
